You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仟源醫藥(300254.SZ):嘉逸醫藥已辦理完成工商登記變更手續
格隆匯 12-17 16:03

格隆匯12月17日丨仟源醫藥(300254.SZ)公佈,公司分別於2019年11月15日、2019年12月2日召開了第三屆董事會第三十六次會議、2019年第一次臨時股東大會,經審議均通過了《關於投資控股子公司暨受讓江蘇嘉逸醫藥有限公司部分股權並對其增資的議案》,同意公司、南通恆嘉藥業有限公司(“SPV公司”)與JOY GLORY INVESTMENT LIMITED嘉逸投資有限公司(Hong Kong)(“嘉逸投資”)、黃樂羣、江蘇嘉逸醫藥有限公司(“嘉逸醫藥”)共同簽署《股權轉讓協議》,SPV公司以人民幣3.43億元交易價格受讓嘉逸醫藥49%股權。

截止公告日,公司投資控股子公司暨受讓嘉逸醫藥49%股權轉讓完成。近日,嘉逸醫藥已辦理完成工商登記變更手續,並取得了南通市經濟技術開發區市場監督管理局簽發的《營業執照》。公司名稱:江蘇嘉逸醫藥有限公司;經營範圍:生產原料藥(苯磺順阿曲庫銨、培哚普利叔丁胺鹽)、片劑、膠囊劑。醫藥中間體的研發及相關技術諮詢和服務。醫藥技術開發及轉讓;醫藥技術服務;醫藥諮詢服務;藥品銷售與市場推廣服務。(依法須經批准的項目,經相關部門批准後方可開展經營活動)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account